Michigan House Passes Bill Requiring Insurance Coverage for Gender Transition Reversal and Monitoring
Michigan House Bill 4468 proposes significant changes to state health insurance requirements regarding gender transition care. If enacted, the legislation would amend the Insurance Code of 1956 to mandate that health insurers provide coverage for three specific categories of care: all possible adverse consequences of gender transition procedures, annual mental and physical health monitoring for enrollees who have undergone such procedures, and any treatments necessary to reverse a gender transition. The bill defines "gender transition" broadly to include medical processes that alter anatomy, physiology, or mental state to assist an individual’s identification as a member of the opposite biological sex.
The measure passed the Michigan House of Representatives on June 3, 2026, with a vote of 58 yeas to 48 nays. It was subsequently transmitted to the Senate, where it was referred to the Committee on Government Operations on June 10, 2026. As of the latest available records, the bill has not been signed into law and remains pending in the Senate committee process. For more context on how legislative proposals move through the state capitol, readers can visit the Michigan voter initiatives and community proposals homepage.
What the bill would do
House Bill 4468 adds a new section, 3406ww, to the Insurance Code of 1956. This section imposes specific coverage mandates on insurers that deliver, issue, or renew health insurance policies in Michigan. The required coverage applies only if the enrollee was covered under the policy at the time the initial gender transition procedure or treatment occurred.
The bill outlines three primary coverage requirements:
- Adverse Consequences: Insurers must cover "all possible adverse consequences" related to an enrollee’s gender transition procedure or treatment. This includes any short- or long-term side effects resulting from the procedure or treatment. The text does not limit this to medically recognized complications but uses the broader phrase "all possible adverse consequences."
- Annual Monitoring: Insurers must cover any testing or screening necessary to monitor the mental and physical health of the enrollee on at least an annual basis. This requirement applies specifically to enrollees who have undergone a gender transition procedure or treatment.
- Reversal Procedures: Insurers must cover any procedure or treatment necessary to reverse the enrollee’s gender transition procedure or treatment. This could include surgical reversals, hormone therapy adjustments, or other medical interventions aimed at restoring pre-transition anatomy or physiology.
The legislation provides statutory definitions for key terms. "Gender transition" is defined as a medical process by which an individual’s anatomy, physiology, or mental state is treated or altered. This definition explicitly includes the removal of otherwise healthy organs or tissue, the introduction of implants, plastic surgery, hormone treatment, and the use of drugs, counseling, or therapy. The purpose of these alterations, as defined in the bill, is to further or assist the individual’s identification as a member of the opposite biological sex or a demographic category that does not correspond to their biological sex. "Gender transition procedure or treatment" is defined as any medical procedure or treatment performed for the purpose of assisting an individual with gender transition.
Questions raised by the text
The text of the bill raises several questions regarding implementation and impact. Proponents may view the mandate for coverage of adverse consequences as a patient safety measure, ensuring that insurers remain accountable for the outcomes of covered treatments. The requirement for annual monitoring could be seen as a proactive health measure facilitating early detection of health issues. Additionally, the mandate for reversal coverage provides an option for individuals who may experience negative consequences from prior transition-related care.
Conversely, the broad scope of the mandated coverage raises questions about financial liability. The phrase "all possible adverse consequences" creates a wide potential scope for claims. Critics may question how this lack of specificity could affect premiums for all policyholders, as insurers adjust rates to account for potential high-cost claims. The fiscal impact of such mandates is a point of consideration, though specific cost estimates are not included in the current record.
Further questions arise regarding the mandate for reversal procedures and annual monitoring. Some may argue that mandating coverage for reversal procedures implies a specific viewpoint on gender transition care. Others may question whether the requirement for annual monitoring is medically necessary for all enrollees who have undergone transition, depending on individual health status. These considerations highlight the complex interplay between insurance mandates, clinical practice, and patient autonomy.
Who may be affected
The primary groups affected by House Bill 4468 include holders of health insurance policies in Michigan, health insurers operating in the state, and individuals who have undergone or are undergoing gender transition procedures or treatments. Insurers would need to adjust their policy terms and claims processing systems to comply with the new coverage mandates. Enrollees who have undergone gender transition would gain guaranteed access to coverage for adverse consequences, annual monitoring, and reversal procedures, provided they were covered at the time of the initial treatment.
Healthcare providers who perform gender transition procedures, monitor post-transition health, or perform reversal surgeries may see changes in patient volume and reimbursement patterns. The bill’s definitions and coverage requirements could influence clinical practices and billing procedures across the state.
What the vote record shows
House Bill 4468 passed the Michigan House of Representatives on June 3, 2026. The roll call vote, recorded as Roll Call #178, resulted in 58 yeas and 48 nays, with no excused absences or members not voting. The vote followed a motion to discharge the bill from committee and place it on immediate passage. Prior to the final passage, the bill was reported with a recommendation for referral to the Committee on Government Operations on May 13, 2026, a motion that passed with 10 yeas and 0 nays.
All listed sponsors of the bill are members of the Republican party, including Representatives Tom Kunse, Pat Outman, Angela Rigas, Gina Johnsen, Gregory Markkanen, Joseph Pavlov, Matthew Maddock, Joseph Fox, Jaime Greene, Brad Paquette, David Martin, Josh Schriver, Jason Woolford, Jennifer Wortz, and Luke Meerman.
What happens next
Following its passage in the House, House Bill 4468 was transmitted to the Senate. On June 10, 2026, the Senate referred the bill to the Committee on Government Operations. The bill has not yet been scheduled for a hearing or vote in the Senate committee. For the bill to become law, it must pass both chambers of the Legislature in identical form and be presented to the Governor for signature or veto. Readers interested in tracking the progress of this and other legislative measures can explore the Power the People Michigan civic reporting library for ongoing updates and analysis.